Abstract:
Pulmonary hypertension (PH), concomitant with chronic kidney disease (CKD),
is a serious but insufficiently focused disease and can lead to life-threatening conditions.
Pathogenesis of LH is specific in CKD, and early diagnosis and timely appropriate treatment are
important. Many studies have shown that the incidence of PH in CKD reaches almost 80% and in
the future, is associated with an increase in mortality. WHO classified PH in CKD as group 5,
that is, a polyetiological group of unclear genesis. Medical treatment of PH in patients with CKD
is not very different from other etiologies. However, it should be understood that PH per se can
be multifactorial, other secondary causes must also be recognized and addressed accordingly. In
this article, we will try to discuss the concept of PH in the concept of CKD and treatment options.
